177 related articles for article (PubMed ID: 18080815)
1. Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation.
Moresco RM; Lavazza T; Belloli S; Lecchi M; Pezzola A; Todde S; Matarrese M; Carpinelli A; Turolla E; Zimarino V; Popoli P; Malgaroli A; Fazio F
Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):704-15. PubMed ID: 18080815
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: comparison with the dopamine receptor imaging.
Ishiwata K; Ogi N; Hayakawa N; Oda K; Nagaoka T; Toyama H; Suzuki F; Endo K; Tanaka A; Senda M
Ann Nucl Med; 2002 Nov; 16(7):467-75. PubMed ID: 12508837
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
[TBL] [Abstract][Full Text] [Related]
4. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
[TBL] [Abstract][Full Text] [Related]
5. Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum.
Levivier M; Gash DM; Przedborski S
Neuroscience; 1995 Nov; 69(1):43-50. PubMed ID: 8637631
[TBL] [Abstract][Full Text] [Related]
6. Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum.
Ryu JK; Choi HB; McLarnon JG
Neurobiol Dis; 2005 Nov; 20(2):550-61. PubMed ID: 15916899
[TBL] [Abstract][Full Text] [Related]
7. Expression of interleukin 6 in the rat striatum following stereotaxic injection of quinolinic acid.
Schiefer J; Töpper R; Schmidt W; Block F; Heinrich PC; Noth J; Schwarz M
J Neuroimmunol; 1998 Aug; 89(1-2):168-76. PubMed ID: 9726839
[TBL] [Abstract][Full Text] [Related]
8. VEGF receptor antagonist Cyclo-VEGI reduces inflammatory reactivity and vascular leakiness and is neuroprotective against acute excitotoxic striatal insult.
Ryu JK; McLarnon JG
J Neuroinflammation; 2008 May; 5():18. PubMed ID: 18492281
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
10. Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease.
Scattoni ML; Valanzano A; Popoli P; Pezzola A; Reggio R; Calamandrei G
Behav Brain Res; 2004 Jul; 152(2):375-83. PubMed ID: 15196806
[TBL] [Abstract][Full Text] [Related]
11. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
Araujo DM; Hilt DC
Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
[TBL] [Abstract][Full Text] [Related]
12. Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.
Popoli P; Pintor A; Domenici MR; Frank C; Tebano MT; Pèzzola A; Scarchilli L; Quarta D; Reggio R; Malchiodi-Albedi F; Falchi M; Massotti M
J Neurosci; 2002 Mar; 22(5):1967-75. PubMed ID: 11880527
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of intrastriatal injection of rapamycin in a mouse model of excitotoxicity induced by quinolinic acid.
Saliba SW; Vieira EL; Santos RP; Candelario-Jalil E; Fiebich BL; Vieira LB; Teixeira AL; de Oliveira AC
J Neuroinflammation; 2017 Jan; 14(1):25. PubMed ID: 28143498
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone.
Ishiwata K; Ogi N; Hayakawa N; Umegaki H; Nagaoka T; Oda K; Toyama H; Endo K; Tanaka A; Senda M
Nucl Med Biol; 2002 Apr; 29(3):307-16. PubMed ID: 11929700
[TBL] [Abstract][Full Text] [Related]
15. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration.
Bazzett TJ; Becker JB; Kaatz KW; Albin RL
Exp Neurol; 1993 Apr; 120(2):177-85. PubMed ID: 8387931
[TBL] [Abstract][Full Text] [Related]
16. Microglial activation correlates with severity in Huntington disease: a clinical and PET study.
Pavese N; Gerhard A; Tai YF; Ho AK; Turkheimer F; Barker RA; Brooks DJ; Piccini P
Neurology; 2006 Jun; 66(11):1638-43. PubMed ID: 16769933
[TBL] [Abstract][Full Text] [Related]
17. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
Massieu L; Thedinga KH; McVey M; Fagg GE
Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
[TBL] [Abstract][Full Text] [Related]
18. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
Reynolds DS; Carter RJ; Morton AJ
J Neurosci; 1998 Dec; 18(23):10116-27. PubMed ID: 9822765
[TBL] [Abstract][Full Text] [Related]
19. Dopamine-glutamate interactions in the striatum: behaviourally relevant modification of excitotoxicity by dopamine receptor-mediated mechanisms.
Garside S; Furtado JC; Mazurek MF
Neuroscience; 1996 Dec; 75(4):1065-74. PubMed ID: 8938742
[TBL] [Abstract][Full Text] [Related]
20. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Anderson KD; Chen Q; Veenman CL; Reiner A
Exp Neurol; 1994 Sep; 129(1):37-56. PubMed ID: 7925841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
